Seagen Inc. Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 2,963 | 0 | 24,763 | 21.8 K to 24.8 K (+13.59 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Seth Alpna | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Seth Alpna | Director | Grant | A | 0.00 | 2,963 | 0 | 8,713 | 5.8 K to 8.7 K (+51.53 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 2,963 | 0 | 131,313 | 128.4 K to 131.3 K (+2.31 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Grant | A | 0.00 | 2,963 | 0 | 48,013 | 45.1 K to 48 K (+6.58 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Option Exercise | A | 64.38 | 48,279 | 3,108,202 | 48,279 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Option Exercise | A | 64.38 | 6,212 | 399,929 | 6,212 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Grant | A | 0.00 | 4,741 | 0 | 28,298 | 23.6 K to 28.3 K (+20.13 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Grant | A | 0.00 | 23,557 | 0 | 23,557 | 0 to 23.6 K |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 2,963 | 0 | 40,168 | 37.2 K to 40.2 K (+7.96 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 2,963 | 0 | 24,763 | 21.8 K to 24.8 K (+13.59 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 2,963 | 0 | 72,763 | 69.8 K to 72.8 K (+4.24 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 2,963 | 0 | 24,763 | 21.8 K to 24.8 K (+13.59 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Seth Alpna | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Seth Alpna | Director | Grant | A | 0.00 | 2,963 | 0 | 8,713 | 5.8 K to 8.7 K (+51.53 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 2,963 | 0 | 131,313 | 128.4 K to 131.3 K (+2.31 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Grant | A | 0.00 | 2,963 | 0 | 48,013 | 45.1 K to 48 K (+6.58 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Option Exercise | A | 64.38 | 48,279 | 3,108,202 | 48,279 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Option Exercise | A | 64.38 | 6,212 | 399,929 | 6,212 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Grant | A | 0.00 | 4,741 | 0 | 28,298 | 23.6 K to 28.3 K (+20.13 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | TAYLOR ROBIN G | Chief Commercial Of ... | Grant | A | 0.00 | 23,557 | 0 | 23,557 | 0 to 23.6 K |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 2,963 | 0 | 40,168 | 37.2 K to 40.2 K (+7.96 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 2,963 | 0 | 24,763 | 21.8 K to 24.8 K (+13.59 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 2,963 | 0 | 72,763 | 69.8 K to 72.8 K (+4.24 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,963 | 0 | 45,842,649 | 45.8 M to 45.8 M (+0.01 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,963 | 0 | 5,304,837 | 5.3 M to 5.3 M (+0.06 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 1,930 | 23,469 | 60,445 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 2,894 | 35,191 | 62,375 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 1,593 | 19,371 | 65,269 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 13,431 | 163,321 | 66,862 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 12.16 | 300 | 3,648 | 80,293 | |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 66.93 | 1,930 | 129,175 | 749,169 | 751.1 K to 749.2 K (-0.26 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 1,930 | 23,469 | 751,099 | 749.2 K to 751.1 K (+0.26 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.77 | 2,894 | 196,126 | 749,169 | 752.1 K to 749.2 K (-0.38 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 2,894 | 35,191 | 752,063 | 749.2 K to 752.1 K (+0.39 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.41 | 1,593 | 107,384 | 749,169 | 750.8 K to 749.2 K (-0.21 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 1,593 | 19,371 | 750,762 | 749.2 K to 750.8 K (+0.21 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.35 | 13,431 | 918,009 | 749,169 | 762.6 K to 749.2 K (-1.76 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 13,431 | 163,321 | 762,600 | 749.2 K to 762.6 K (+1.79 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.91 | 300 | 20,673 | 749,169 | 749.5 K to 749.2 K (-0.04 %) |
| May 10 2019 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 12.16 | 300 | 3,648 | 749,469 | 749.2 K to 749.5 K (+0.04 %) |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 8.38 | 10,000 | 83,800 | 0 | |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 8.38 | 10,000 | 83,800 | 0 | |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 8.38 | 10,000 | 83,800 | 45,839,686 | 45.8 M to 45.8 M (+0.02 %) |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 8.38 | 10,000 | 83,800 | 5,301,874 | 5.3 M to 5.3 M (+0.19 %) |